Theralase Technologies Inc logo

TLT - Theralase Technologies Inc Share Price

C$0.275 0.0  0.0%

Last Trade - 13/04/21

Micro Cap
Market Cap £32.5m
Enterprise Value £27.5m
Revenue £566k
Position in Universe 1105th / 2712
Unlock TLT Revenue
Relative Strength (%)
1m -3.18%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -14.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
1.38 1.95 1.92 2.34 1.73 0.96 0.63 0.80 -6.9%
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2020,Theralase Technologies Inc. revenues increased 2% toC$527K. Net loss applicable to common stockholdersincreased 7% to C$4.7M. Revenues reflect United Statessegment increase from C$24K to C$52K, International segmentincrease of 93% to C$26K. Higher net loss reflects Researchand development expenses - Bala increase of 26% to C$2.7M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


TLT Revenue Unlock TLT Revenue

Net Income

TLT Net Income Unlock TLT Revenue

Normalised EPS

TLT Normalised EPS Unlock TLT Revenue

PE Ratio Range

TLT PE Ratio Range Unlock TLT Revenue

Dividend Yield Range

TLT Dividend Yield Range Unlock TLT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
TLT EPS Forecasts Unlock TLT Revenue
Profile Summary

Theralase Technologies Inc. is a biotech company focused on the commercialization of medical devices to eliminate pain and the development of Photo Dynamic Compounds (PDCs) to destroy cancer. The Company operates through two divisions: Therapeutic Laser Technology (TLT) division and Photo Dynamic Therapy (PDT) division. The TLT division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology is used for healing a range of nerve, muscle and joint conditions, including arthritis, osteoarthritis and wounds. The PDT division develops PDCs and activates them with laser technology to destroy specifically targeted cancers and bacteria. Its TLC-2000 Biofeedback Therapeutic Laser Technology possesses Cell Sensing technology that senses and targets injured tissue. It is also developing TLC-1000 therapeutic medical laser system. It is developing TLC-3000 medical laser system for the treatment of a range of cancers.

Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated August 22, 1989
Public Since November 2, 2004
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange TSX Venture Exchange
Shares in Issue 204,275,875
Free Float (0.0%)
Eligible for
TLT Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for TLT
Upcoming Events for TLT
Tuesday 27th April, 2021 Estimate
Q4 2020 Theralase Technologies Inc Earnings Release
Thursday 27th May, 2021 Estimate
Q1 2021 Theralase Technologies Inc Earnings Release
Thursday 26th August, 2021 Estimate
Q2 2021 Theralase Technologies Inc Earnings Release
Friday 24th September, 2021 Estimate
Theralase Technologies Inc Annual Shareholders Meeting
Frequently Asked Questions for Theralase Technologies Inc
What is the Theralase Technologies Inc share price?

As of 13/04/21, shares in Theralase Technologies Inc are trading at C$0.275, giving the company a market capitalisation of £32.5m. This share price information is delayed by 15 minutes.

How has the Theralase Technologies Inc share price performed this year?

Shares in Theralase Technologies Inc are currently trading at C$0.275 and the price has moved by 41.03% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Theralase Technologies Inc price has moved by 3.24% over the past year.

What are the analyst and broker recommendations for Theralase Technologies Inc?

Of the analysts with advisory recommendations for Theralase Technologies Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Theralase Technologies Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Theralase Technologies Inc next release its financial results?

Theralase Technologies Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Theralase Technologies Inc dividend yield?

Theralase Technologies Inc does not currently pay a dividend.

Does Theralase Technologies Inc pay a dividend?

Theralase Technologies Inc does not currently pay a dividend.

When does Theralase Technologies Inc next pay dividends?

Theralase Technologies Inc does not currently pay a dividend.

How do I buy Theralase Technologies Inc shares?

To buy shares in Theralase Technologies Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Theralase Technologies Inc?

Shares in Theralase Technologies Inc are currently trading at C$0.275, giving the company a market capitalisation of £32.5m.

Where are Theralase Technologies Inc shares listed? Where are Theralase Technologies Inc shares listed?

Here are the trading details for Theralase Technologies Inc:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: TLT
What kind of share is Theralase Technologies Inc?

Based on an overall assessment of its quality, value and momentum, Theralase Technologies Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Theralase Technologies Inc share price forecast 2021?

Shares in Theralase Technologies Inc are currently priced at C$0.275. At that level they are trading at 0.155% discount to the analyst consensus target price of 0.00.

Analysts covering Theralase Technologies Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.03 for the next financial year.

How can I tell whether the Theralase Technologies Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Theralase Technologies Inc. Over the past six months, the relative strength of its shares against the market has been 57.33%. At the current price of C$0.275, shares in Theralase Technologies Inc are trading at 36.71% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Theralase Technologies Inc PE Ratio?

We were not able to find PE ratio data for Theralase Technologies Inc.

Who are the key directors of Theralase Technologies Inc?

Theralase Technologies Inc's management team is headed by:

Kristina Hachey - CFO
Randall Bruder - IND
Matthew Perraton - IND
Guy Anderson - NEC
Shawn Shirazi - CEO
Arkady Mandel - CSO
Who are the major shareholders of Theralase Technologies Inc?

Here are the top five shareholders of Theralase Technologies Inc based on the size of their shareholding:

Bruder, Randall Individual Investor
Percentage owned: 0.85% (1.74m shares)
Hachey (Kristina) Individual Investor
Percentage owned: 0.79% (1.62m shares)
Anderson (Guy John) Individual Investor
Percentage owned: 0.32% (656k shares)
Lade (Kipton) Individual Investor
Percentage owned: 0.08% (167k shares)
Capwealth Advisors, LLC Investment Advisor
Percentage owned: 0.05% (103k shares)
Similar to TLT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.